摘要
目的:探讨分别应用常规适形CRT与调强放疗技术IMRT治疗胸腺肿瘤的剂量分布优劣。材料与方法:选取8例胸腺肿瘤患者,分别制作适形与调强计划,所有计划均给予60Gy和70Gy两种处方剂量。对于计划的剂量体积直方图(DVH)、计划靶区(PTV)的靶区适形指数(CI)和靶区均匀指数(HI)以及正常组织的最大或最小剂量等指标进行分析。结果:调强计划的计划靶区CI及HI指数为0.77和1.04,适形计划为0.52和1.13。调强计划对于肺、脊髓、食道、气管、心脏和胸骨这些正常组织均显示出更好的保护效果。调强计划的肺V20和平均剂量为15.6%和8.67Gy,适形计划为18.8%和9.62Gy;调强计划的脊髓D1%为37.42Gy,适形计划为44.05Gy;调强计划的气管V30和平均剂量为32.61%和21.24Gy,适形计划为43.00%和24.73Gy;调强计划的食道V50和平均剂量为9.04%和21.74Gy,适形计划为18.96%和24.32Gy;调强计划的心脏V40和平均剂量为11.16%和11.29Gy,适形计划为13.93%和11.47Gy;调强计划的胸骨最大剂量和平均剂量为65.38Gy和43.50Gy,适形计划为68.96Gy和47.03Gy。结论:调强计划能够在提高靶区适形度和均匀性的同时,降低正常器官受量。
Objective: To evaluate the optimized conformal and IMRT plans for the patients with thymoma and thymic carcino- ma. Methods: For 8 patients with thymoma and thymic carcinoma, CRT and IMRT planning were preformed. Target doses for plans were 60 and 70 Gy. Plans were compared according to dose-volume histogram (DVH) analysis including conformity and homogeneity indices (CI and H/) of planning target volumes (PTVs), and maximum or mean doses to normal structures. Re- suits: CIs and His for IMRT plans were 0.77 and 1.04 while CRT 0.52 and 1.13. IMRT plans resulted in a better normal tissue sparing to Lung, Spinal Cord, Esophagus, Trachea, Heart and Stemal bone. V20 and Mean Dose of Lung were 15.6% and 8.67Gy (IMRT) vs. 18.8% and 9.62 Gy(CRT); Din of Spinal cord was 37.42(IMRT) vs. 44.05(CRT); V30 and Mean Dose of Trachea were 32.61% and 21.24 Gy (IMRT) vs. 43.00% and 24.73 Gy (CRT); Vs0 and Mean Dose of Esophagus were 9.04% and 21.74 Gy (IMRT) vs. 18.96% and 24.32 Gy(CRT); V4o and Mean Dose of Heart were 11.16% and 11.29 Gy (IMRT) vs. 13.93% arkl 11.47 Gy (CRT); Dmax and Mean Dose of provides superior target volume coverage and conformality, with de- creased dose to normal structures.
出处
《中国医学物理学杂志》
CSCD
2010年第1期1603-1606,1624,共5页
Chinese Journal of Medical Physics
关键词
胸腺瘤/胸腺癌
放射治疗
适形
调强
剂量
thymoma/ thymic carcinoma
radiotherapy
conformal
intensity modulated
dosimetry